南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2010年
2期
236-238
,共3页
李秋华%全松%陈雷宁%李红%高瑞花%倪都%余敏%陈思梅%罗琛
李鞦華%全鬆%陳雷寧%李紅%高瑞花%倪都%餘敏%陳思梅%囉琛
리추화%전송%진뢰저%리홍%고서화%예도%여민%진사매%라침
重复辅助生殖周期%体外受精-胚胎移植%妊娠率%年龄
重複輔助生殖週期%體外受精-胚胎移植%妊娠率%年齡
중복보조생식주기%체외수정-배태이식%임신솔%년령
repeated assisted reproductive technology cycles%in vitro fertilization and embryo transfer%pregnancy rate%age
目的 探讨重复周期妊娠成功的影响因素.方法 回顾分析我院生殖中心2006年1月~2009年4月89例行第2个体外受精-胚胎移植(IVF/ICSI-ET)周期妊娠患者(A组)和71例行第2个周期均未妊娠的患者(B组),分析2组患者基本情况、临床方案、卵母细胞和胚胎质量等因素对妊娠结局的影响.结果 A组与B组相比,A组女方年龄较小、不孕年限短、基础卵泡数较多,且前者Gn总量少,但A组优质胚胎率、可移植胚胎数均高于B组(P<0.05).A组第2个周期比第1个周期应用较多的GnRHa短效制剂、基因重组HCG、加用HMG、有较高的HCG日血中E2浓度,且优质胚胎率、可移植胚胎数、移植胚胎数等第2周期均比第1周期高(多)(P<0.05).结论女性年龄是影响辅助生殖技术成功的重要因素之一;在重复IVF-ET周期中通过采用黄体期长方案及调节Gn的用量、调整GnRHa的制剂、适量加用HMG、应用口服避孕药预处理、更换培养基等措施可能有助于提高临床妊娠率.
目的 探討重複週期妊娠成功的影響因素.方法 迴顧分析我院生殖中心2006年1月~2009年4月89例行第2箇體外受精-胚胎移植(IVF/ICSI-ET)週期妊娠患者(A組)和71例行第2箇週期均未妊娠的患者(B組),分析2組患者基本情況、臨床方案、卵母細胞和胚胎質量等因素對妊娠結跼的影響.結果 A組與B組相比,A組女方年齡較小、不孕年限短、基礎卵泡數較多,且前者Gn總量少,但A組優質胚胎率、可移植胚胎數均高于B組(P<0.05).A組第2箇週期比第1箇週期應用較多的GnRHa短效製劑、基因重組HCG、加用HMG、有較高的HCG日血中E2濃度,且優質胚胎率、可移植胚胎數、移植胚胎數等第2週期均比第1週期高(多)(P<0.05).結論女性年齡是影響輔助生殖技術成功的重要因素之一;在重複IVF-ET週期中通過採用黃體期長方案及調節Gn的用量、調整GnRHa的製劑、適量加用HMG、應用口服避孕藥預處理、更換培養基等措施可能有助于提高臨床妊娠率.
목적 탐토중복주기임신성공적영향인소.방법 회고분석아원생식중심2006년1월~2009년4월89례행제2개체외수정-배태이식(IVF/ICSI-ET)주기임신환자(A조)화71례행제2개주기균미임신적환자(B조),분석2조환자기본정황、림상방안、란모세포화배태질량등인소대임신결국적영향.결과 A조여B조상비,A조녀방년령교소、불잉년한단、기출란포수교다,차전자Gn총량소,단A조우질배태솔、가이식배태수균고우B조(P<0.05).A조제2개주기비제1개주기응용교다적GnRHa단효제제、기인중조HCG、가용HMG、유교고적HCG일혈중E2농도,차우질배태솔、가이식배태수、이식배태수등제2주기균비제1주기고(다)(P<0.05).결론녀성년령시영향보조생식기술성공적중요인소지일;재중복IVF-ET주기중통과채용황체기장방안급조절Gn적용량、조정GnRHa적제제、괄량가용HMG、응용구복피잉약예처리、경환배양기등조시가능유조우제고림상임신솔.
Objective To study the clinical factors affecting the outcomes of repeated assisted reproductive technology (ART)cycles. Methods A retrospective analysis of the clinical data and outcomes was conducted among 160 patients undergoing repeated IVF/ICSI-ET treatment between January 2006 and April 2009. Results The patients with successful clinical pregnancy after two ART cycles (group A) had a younger age and shorter duration of infertility, and had more antral follicles (AFC), more eggs and good-quality embryos with more transferred embryos available and higher good-quality embryo rate (P<0.05) than those who failed to have pregnancy after the cycles (group B). In the second cycle, the patients in group A had higher doses of short-acting GnRHa, r-HCG and HMG and at the same time more good eggs and embryos than in the first cycle. Conclusion Female age is one of the most important factors affecting the pregnancy rate after repeated ART cycles. The clinical pregnancy rate can be enhanced by administering short-acting GnRHa, HMG, oral contraceptives and adjusting the dose of Gn as well as changing the culture medium of embryos.